Return to Today's science sparks archives

2019-07-01

Fig 2. Response of patients with epithelial ovarian cancer by germline BRCA mutation status

Fig 2. Response of patients with epithelial ovarian cancer by germline BRCA mutation status
  • Konstantinopoulos PA, Barry WT, Birrer M, Westin SN, Cadoo KA, Shapiro GI, Mayer EL, O'Cearbhaill RE, Coleman RL, Kochupurakkal B, Whalen C, Curtis J, Farooq S, Luo W, Eismann J, Buss MK, Aghajanian C, Mills GB, Palakurthi S, Kirschmeier P, Liu J, Cantley LC, Kaufmann SH, Swisher EM, D'Andrea AD, Winer E, Wulf GM, Matulonis UA

  • Lancet Oncol. 2019 Apr;20(4):570-580.

2019-07-02

Fig. 1. Identification of an additional protein–DNA interface in the crystal structure of the SRY.h-cGASCD–DNA complex.

Fig. 1. Identification of an additional protein–DNA interface in the crystal structure of the SRY.h-cGASCD–DNA complex.
  • Xie W, Lama L, Adura C, Tomita D, Glickman JF, Tuschl T, Patel DJ

  • Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11946-11955.

2019-07-03

Fig 1. Schematic outlining key findings from the work of Zhou and colleagues.

Fig 1. Schematic outlining key findings from the work of Zhou and colleagues.
  • Shoushtari AN

  • Clin Cancer Res. 2019 Jun 15;25(12):3473-3475.

2019-07-05

Fig. 4. Endoderm repolarization: the different ways cells can re-polarize.

Fig. 4. Endoderm repolarization: the different ways cells can re-polarize.
  • Nowotschin S, Hadjantonakis AK, Campbell K

  • Development. 2019 Jun 3;146(11).
Open Access button

2019-07-08

Central Illustration. Core Components Necessary for Preparing the Cardio-Oncology Workforce

Central Illustration. Core Components Necessary for Preparing the Cardio-Oncology Workforce
  • Hayek SS, Ganatra S, Lenneman C, Scherrer-Crosbie M, Leja M, Lenihan DJ, Yang E, Ryan TD, Liu J, Carver J, Mousavi N, O'Quinn R, Arnold A, Banchs J, Barac A, Ky B

  • J Am Coll Cardiol. 2019 May 7;73(17):2226-2235.

2019-07-09

Fig. 2. The a) preoperative and b) postoperative T2W midsagittal MRI images showing the VUJ, PMU and ARJ anatomical landmarks.

Fig. 2. The a) preoperative and b) postoperative T2W midsagittal MRI images showing the VUJ, PMU and ARJ anatomical landmarks.
  • Ha HK, Luiting HB, Graham PL, Patel MI, Sandhu JS, Akin O, Mungovan SF

  • BMC Urol. 2019 Jun 18;19(1):54.
Open Access button

2019-07-10

Fig 1. Targeted Sequencing in MyM Patients.

Fig 1. Targeted Sequencing in MyM Patients.
  • Epstein-Peterson ZD, Devlin SM, Stein EM, Klimek VM, Saltz LB, Tallman MS

  • Leuk Res. 2019 Jul;82:19-23.

2019-07-11

Fig 1. ATM deficiency impairs CSR in vitro.

Fig 1. ATM deficiency impairs CSR in vitro.
  • Nicolas L, Cols M, Smolkin R, Fernandez KC, Yewdell WT, Yen WF, Zha S, Vuong BQ, Chaudhuri J

  • J Immunol. 2019 Jun 1;202(11):3137-3142.

2019-07-12

Figure 2. Interaction between the B‐cell receptor (BCR) signaling and the Toll‐like receptor (TLR) signaling pathways.

Figure 2. Interaction between the B‐cell receptor (BCR) signaling and the Toll‐like receptor (TLR) signaling pathways.
  • Younes A

  • Hematol Oncol. 2019 Jun;37 Suppl 1:105-109.

2019-07-15

Fig. 3. Evaluation of macrophage chemoattractant and proliferation in the irreversible electroporation (IRE)-treated ureter.

Fig. 3. Evaluation of macrophage chemoattractant and proliferation in the irreversible electroporation (IRE)-treated ureter.
  • Ueshima E, Fujimori M, Kodama H, Felsen D, Chen J, Durack JC, Solomon SB, Coleman JA, Srimathveeravalli G

  • Am J Physiol Renal Physiol. 2019 Jul 1;317(7):F52-F64.

2019-07-17

Fig 1. Schematic design principle of FRNPs.

Fig 1. Schematic design principle of FRNPs.
  • Pal S, Ray A, Andreou C, Zhou Y, Rakshit T, Wlodarczyk M, Maeda M, Toledo-Crow R, Berisha N, Yang J, Hsu HT, Oseledchyk A, Mondal J, Zou S, Kircher MF

  • Nat Commun. 2019 Apr 26;10(1):1926.
Open Access button

2019-07-18

Figure 4. Bioinformatics Analyses of Illumina HT Sequencing Data from LIGS Libraries.

Figure 4. Bioinformatics Analyses of Illumina HT Sequencing Data from LIGS Libraries.
  • Zumrut HE, Batool S, Argyropoulos KV, Williams N, Azad R, Mallikaratchy PR

  • Mol Ther Nucleic Acids. 2019 Jun 4;17:150-163.
Open Access button

2019-07-19

Fig. 4. 70-year-old man with primary cSCC in scalp underwent staging.

Fig. 4. 70-year-old man with primary cSCC in scalp underwent staging.
  • Mahajan S, Barker CA, Singh B, Pandit-Taskar N

  • Nucl Med Commun. 2019 Jul;40(7):744-751.

2019-07-22

Fig 1A. Menin-Independent Activity of MI-2 in Glioma.

Fig 1A. Menin-Independent Activity of MI-2 in Glioma.
  • Phillips RE, Yang Y, Smith RC, Thompson BM, Yamasaki T, Soto-Feliciano YM, Funato K, Liang Y, Garcia-Bermudez J, Wang X, Garcia BA, Yamasaki K, McDonald JG, Birsoy K, Tabar V, Allis CD

  • Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7957-7962.

2019-07-23

Fig 1. Theoretical diagram of context‐based image retrieval.

Fig 1. Theoretical diagram of context‐based image retrieval.
  • Rotemberg V, Halpern A

  • Br J Dermatol. 2019 Jul;181(1):5-6.
Open Access button

2019-07-24

Potential units that are adequately dosed for a 70-kg patient.

Potential units that are adequately dosed for a 70-kg patient.
  • Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, Politikos I, Shpall EJ, Scaradavou A, Dehn J

  • Blood Adv. 2019 Apr 23;3(8):1267-1271.
Open Access button

2019-07-25

Fig 3. Absence of BRCA-driven HRD in MM.

Fig 3. Absence of BRCA-driven HRD in MM.
  • Maura F, Degasperi A, Nadeu F, Leongamornlert D, Davies H, Moore L, Royo R, Ziccheddu B, Puente XS, Avet-Loiseau H, Cambell PJ, Nik-Zainal S, Campo E, Munshi N, Bolli N

  • Nat Commun. 2019 Jul 5;10(1):2969.

2019-07-26

FIG 4. Sublineages coexist after rapid diversification, in which the pbp5 mutation becomes fixed in the total intestinal VRE population.

FIG 4. Sublineages coexist after rapid diversification, in which the pbp5 mutation becomes fixed in the total intestinal VRE population.
  • Dubin KA, Mathur D, McKenney PT, Taylor BP, Littmann ER, Peled JU, van den Brink MRM, Taur Y, Pamer EG, Xavier JB

  • Infect Immun. 2019 Jun 20;87(7). pii: e00102-19.
Open Access button

2019-07-29

Fig 2. Spectrum of adult and pediatric tumors harboring NTRK gene fusions. GIST, gastrointestinal stromal tumor.

Fig 2. Spectrum of adult and pediatric tumors harboring NTRK gene fusions. GIST, gastrointestinal stromal tumor.
  • Hsiao SJ, Zehir A, Sireci AN, Aisner DL

  • J Mol Diagn. 2019 Jul;21(4):553-571.
Open Access button

2019-07-30

Graphical Abstract

Graphical Abstract
  • Li J, Dong A, Saydaminova K, Chang H, Wang G, Ochiai H, Yamamoto T, Pertsinidis A

  • Cell. 2019 Jul 11;178(2):491-506.e28.

2019-07-31

Figure 1. Three-Dimensional Imaging Approach Provides Accurate Tissue Volume and Cell Localization

Figure 1. Three-Dimensional Imaging Approach Provides Accurate Tissue Volume and Cell Localization
  • Fu YY, Egorova A, Sobieski C, Kuttiyara J, Calafiore M, Takashima S, Clevers H, Hanash AM

  • Immunity. 2019 Jul 16;51(1):90-103.e3.

2019-08-01

Fig 1. Trp53R172H leads to accelerated onset of hematologic malignancies.

Fig 1. Trp53R172H leads to accelerated onset of hematologic malignancies.
  • Loizou E, Banito A, Livshits G, Ho YJ, Koche RP, Sánchez-Rivera FJ, Mayle A, Chen CC, Kinalis S, Bagger FO, Kastenhuber ER, Durham BH, Lowe SW

  • Cancer Discov. 2019 Jul;9(7):962-979.

2019-08-02

Central Illustration.

Central Illustration.
  • Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J, Zeiher A, Jaiswal S, Schulz C, Blankstein R, Bolton KL, Steensma D, Levine RL, Ebert BL

  • J Am Coll Cardiol. 2019 Jul 30;74(4):567-577.

2019-08-05

Fig 1. (A) T1-weighted post-contrast MRI showing VS (white arrow) at pretreatment baseline (left panel) and after 32 months on treatment with BEV (right panel).

Fig 1. (A) T1-weighted post-contrast MRI showing VS (white arrow) at pretreatment baseline (left panel) and after 32 months on treatment with BEV (right panel).
  • Karajannis MA, Hagiwara M, Schreyer M, Haque S

  • Neuro Oncol. 2019 Jun 10;21(6):822-824.

2019-08-06

Fig 1. Treatment Algorithm 1: First-line treatment for R/M HNSCC patients. Immunotherapy treatment algorithm for R/M Systemic Therapy Naïve HNSCC.

Fig 1. Treatment Algorithm 1: First-line treatment for R/M HNSCC patients. Immunotherapy treatment algorithm for R/M Systemic Therapy Naïve HNSCC.
  • Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL

  • J Immunother Cancer. 2019 Jul 15;7(1):184.
Open Access button

2019-08-07

Fig 2. Pelvic MRI at 10 weeks gestation.

Fig 2. Pelvic MRI at 10 weeks gestation.
  • Ramirez PT, Abu-Rustum NR, Euscher E

  • Int J Gynecol Cancer. 2019 Jan 23. pii: ijgc-2018-000187.
Open Access button

2019-08-08

MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation.

MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation.
  • Fay A, Czudnochowski N, Rock JM, Johnson JR, Krogan NJ, Rosenberg O, Glickman MS

  • MBio. 2019 Jun 25;10(3). pii: e00850-19.
Open Access button

2019-08-09

Fig 2. Efficacy in the intention-to-treat population.

Fig 2. Efficacy in the intention-to-treat population.
  • Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators

  • Lancet Oncol. 2019 Jun;20(6):849-861.

2019-08-12

Fig 1. QC1 pH low insertion peptide (pHLIP) targets acidity at the surface of cancer cells and allows multi-spectral optoacoustic imaging.

Fig 1. QC1 pH low insertion peptide (pHLIP) targets acidity at the surface of cancer cells and allows multi-spectral optoacoustic imaging.
  • Roberts S, Strome A, Choi C, Andreou C, Kossatz S, Brand C, Williams T, Bradbury M, Kircher MF, Reshetnyak YK, Grimm J, Lewis JS, Reiner T

  • Sci Rep. 2019 Jun 12;9(1):8550.
Open Access button

2019-08-13

Fig. 3 TSGs are enriched among CLL-IPAs.

Fig. 3 TSGs are enriched among CLL-IPAs.
  • Lee SH, Singh I, Tisdale S, Abdel-Wahab O, Leslie CS, Mayr C

  • Nature. 2018 Sep;561(7721):127-131.

2019-08-14

Figure 1. Quantitative Proteomic Characterization of Cancer-Associated PP2A-Aα Mutations.

Figure 1. Quantitative Proteomic Characterization of Cancer-Associated PP2A-Aα Mutations.
  • Antao NV, Marcet-Ortega M, Cifani P, Kentsis A, Foley EA

  • iScience. 2019 Jul 17;19:74-82.
Open Access button

2019-08-15

Figure 4. Targeted T cell receptor (TCR) delivery and TCR‐like structures.

Figure 4. Targeted T cell receptor (TCR) delivery and TCR‐like structures.
  • Chandran SS, Klebanoff CA

  • Immunol Rev. 2019 Jul;290(1):127-147.
Open Access button

2019-08-16

Illustration of a PET image of a typical mCRPC patient with extensive [18F]FDHT-avid bone metastases reconstructed with a 100% count EARL1, b 50% count EARL1, c 100% count EARL2, and d 50% count EARL2.

Illustration of a PET image of a typical mCRPC patient with extensive [18F]FDHT-avid bone metastases reconstructed with a 100% count EARL1, b 50% count EARL1, c 100% count EARL2, and d 50% count EARL2.
  • Cysouw MCF, Kramer GM, Heijtel D, Schuit RC, Morris MJ, van den Eertwegh AJM, Voortman J, Hoekstra OS, Oprea-Lager DE, Boellaard R

  • EJNMMI Res. 2019 Jul 30;9(1):70.
Open Access button

2019-08-19

Fig. 2 Principal coordinates analysis (PCoA) plots of stool samples, labelled by necrotizing enterocolitis (NEC) status.

Fig. 2 Principal coordinates analysis (PCoA) plots of stool samples, labelled by necrotizing enterocolitis (NEC) status.
  • Romano-Keeler J, Shilts MH, Tovchigrechko A, Wang C, Brucker RM, Moore DJ, Fonnesbeck C, Meng S, Correa H, Lovvorn HN 3rd, Tang YW, Hooper L, Bordenstein SR, Das SR, Weitkamp JH

  • PLoS One. 2018 Oct 26;13(10):e0206366.
Open Access button

2019-08-20

Fig. 1. The repertoire of somatic mutations in primary SDC detected by the MSK-IMPACT assay.

Fig. 1. The repertoire of somatic mutations in primary SDC detected by the MSK-IMPACT assay.
  • Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.

  • Hum Pathol. 2019 Apr 1. pii: S0046-8177(19)30049-8

2019-08-21

Obesity-induced alterations in periprostatic fat transcriptome are normalized by supplemental E2.

Obesity-induced alterations in periprostatic fat transcriptome are normalized by supplemental E2.
  • Bhardwaj P, Ikeda T, Zhou XK, Wang H, Zheng XE, Giri DD, Elemento O, Verma A, Miyazawa M, Mukherjee S, Falcone DJ, Wendel NK, Scherr DS, Dannenberg AJ

  • Carcinogenesis. 2019 Jul 20;40(7):914-923.
Open Access button

2019-08-22

Figure 1. Experimental Procedure for Generating and Screening Library of Secreted Bacterial Metabolites from Large-Scale Monocultures of SIHUMI Consortium Members.

Figure 1. Experimental Procedure for Generating and Screening Library of Secreted Bacterial Metabolites from Large-Scale Monocultures of SIHUMI Consortium Members.
  • Colosimo DA, Kohn JA, Luo PM, Piscotta FJ, Han SM, Pickard AJ, Rao A, Cross JR, Cohen LJ, Brady SF

  • Cell Host Microbe. 2019 Aug 14;26(2):273-282.e7.
Open Access button

2019-08-23

Fig 2. Considerations for planning preoperative radiation therapy to be delivered before extrapleural pneumonectomy for malignant pleural mesothelioma (the Surgery for Mesothelioma after Radiation Therapy technique).

Fig 2. Considerations for planning preoperative radiation therapy to be delivered before extrapleural pneumonectomy for malignant pleural mesothelioma (the Surgery for Mesothelioma after Radiation Therapy technique).
  • Gomez DR, Rimner A, Simone CB, Cho BCJ, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K

  • J Thorac Oncol. 2019 Jul;14(7):1172-1183.